Bharat Biotech’s nasal vaccine, BBV154, has already completed Phase-2 trials with Covaxin. The proposed Ph-3 trials will cover those who have been administered with any two doses of the Covid-19 vaccine. Vaccine maker Bharat Biotech has sought regulatory nod to conduct Phase-3 trials of its nasal Covid-19 vaccine that can be used as a booster … Read more
The reports had alleged that there were some irregularities associated with the hike in the vaccine price. In a surprising development, Hyderabad-based vaccine maker Bharat Biotech has cancelled the contract to supply its Coronavirus vaccine Covaxin to Brazil. The company in a statement issued on Friday said that it has terminated the contract to supply … Read more
In a significant development, indigenously developed Bharat Biotech’s Coronavirus vaccine Covaxin has been found to be 77.8 percent effective against symptomatic Coronavirus infections, the result of the third phase of clinical trials of the vaccine showed. While the efficacy rate of the vaccine remained 77.8 percent against symptomatic Covid-19 cases, the trial results found that … Read more
The prices for Covid-19 vaccines internationally have varied between Rs 730 to Rs 2,700 per dose. Vaccine maker Bharat Biotech on Tuesday said it was not feasible to price its Covid-19 vaccine, Covaxin at `150 per dose. The company said a higher price in the private markets was required to offset part of the costs … Read more
The broad-based MCA (as the agreement is being referred to) enables the partners to take up futuristic development activities in other related areas as well.” Bharat Biotech International, the company that in collaboration with select government organisations developed Covaxin, one of the two COVID-19 vaccines currently being administered in the country, has now roped in … Read more
The DGCI had said that the decision to grant emergency approval to the vaccine maker was given on the basis of earlier phases of clinical trials. Bharat Biotech, the Hyderabad-based pharma major, has released the efficacy data of its Coronavirus vaccine ‘Covaxin’ on Wednesday. reported. According to news agency ANI, the company said that its … Read more
Soon after the company had been chosen by the DBT for the Rotavirus vaccine, the company shipped out the first batch of vaccine it had developed for Hepatitis B in the year 1999. (Credit: ANI) With the government regulator allowing the emergency use of the Covid-19 vaccine developed by Bharat Biotech, the Hyderabad-based company has … Read more
It is pertinent to note that both Serum Institute of India and Bharat Biotech have got the go ahead from the Drug Controller General of India (DGCI) for the emergency use of their Coronavirus vaccine candidates. Covid-19 vaccine update: A day after Bharat Biotech Chairman Krisha Ella called out Serum Institute chief Adar Poonawala for … Read more